Vitamin K
12001-79-5CC1=C(C/C=C(\C)CCCC(C)CCCC(C)CCCC(C)C)C(=O)c2ccccc2C1=OMBWXNTAXLNYFJB-LKUDQCMESA-N2-methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)naphthalene-1,4-dione is a member of 1,4-naphthoquinones.
12001-79-5、27696-10-2、81818-54-4、84-80-0DTXSID501369321CHEMBL520156CHEBI:94399Breast Feeding; Lactation; Milk, Human; Vitamins; Antifibrinolytic Agents
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Chemical: Vitamin K
Vitamin K: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Currently, there is no known toxicity is associated with high doses of vitamin K1 or vitamin K2. Therefore, there is no designated upper intake level (UL). Despite this, an allergic reaction is possible with either version of vitamin K. Vitamin K1 has had documented associations with bronchospasm and cardiac arrest with IV administration. The oral form of vitamin K does not seem to cause severe reactions.
Subcutaneous, Intramuscular, Intravenous injection. Oral phylloquinone is adequately absorbed from the gastrointestinal tract only if bile salts are present. After absorption, phylloquinone is initially concentrated in the liver, but the concentration declines rapidly. Very little vitamin K accumulates in tissues.
Vitamin K toxicity is extremely rare. The only reported toxicity comes from menadione, which has no use in humans. Its toxicity is thought to be associated with its water-soluble properties. When toxicity does occur, it manifests with signs of jaundice, hyperbilirubinemia, hemolytic anemia, and kernicterus in infants.
Vitamin K is an essential cofactor for the gamma-carboxylase enzymes which catalyze the posttranslational gamma-carboxylation of glutamic acid residues in inactive hepatic precursors of coagulation factors II (prothrombin), VII, IX and X. Gamma-carboxylation converts these inactive precursors into active coagulation factors which are secreted by hepatocytes into the blood. Supplementing with Phylloquinone results in a relief of vitamin K deficiency symptoms which include easy bruisability, epistaxis, gastrointestinal bleeding, menorrhagia and hematuria.
Vitamin K substances
Group 3: Not classifiable as to its carcinogenicity to humans
Volume 76: (2000) Some Antiviral and Antineoplastic Drugs, and Other Pharmaceutical Agents
2000
1999
3, not classifiable as to its carcinogenicity to humans. (L135)
◉ Summary of Use during Lactation
◈ What is vitamin K?
Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders.
Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body.
解説フィロキノンともいう.血液凝固を促進する脂溶性ビタミン.血液凝固に必要な因子のⅡ因子(プロスロンビン)やⅦ因子,Ⅸ因子,Ⅹ因子の生合成に関係する.凝固(Koagulation,独語)のKをとって命名された.1939年,E.A. Doisy(ドイジー)らは,アルファルファ(牧草)と腐敗魚粉から2種類のビタミンK物質を分離して,ビタミン K1,K2 と命名した.これらの物質がキノン構造を有することを推定して,数多くのキノノイドについて検討し,2-メチル-1,4-ナフトキノンが有効であることを明らかにした."これが現在ビタミン K3 とよばれているものである.いずれも水に不溶,有機溶媒に可溶.光,アルカリなどによって容易に分解される.空気,湿気に対しては比較的安定である.なお,出血剤ジクマロールはビタミンKのアンチビタミンである.ビタミン K1:フィロキノン,フィトナジオン,2-メチル-3-フィチル-1,4-ナフトキノンともいう.C31H46O2(450.17).鮮黄色の油.融点-20 ℃.紫外線照射により変性する紫外線.照射により殺菌された牛肉でネズミを飼育すると,ビタミンK欠乏症を示した.森北出版「化学辞典(第2版)